Results 251 to 260 of about 325,231 (306)

Identification of plasma exosomal microRNAs and bioinformatics analysis of the microRNA-messenger RNA regulatory pathways in mice with status epilepticus. [PDF]

Cytotechnology
Wang W, Yin J.
europepmc   +1 more source

Bridging the Gap Between Human Toxicology and Ecotoxicology Under One Health Perspective by a Cross‐Species Adverse Outcome Pathway Network for Reproductive Toxicity

Environmental Toxicology and Chemistry, EarlyView.
Cross‐species extrapolation of adverse outcome pathway network on reproductive toxicity under the One Health perspective using new approach methodologies. AOP = adverse outcome pathway. Abstract Although ecotoxicological and toxicological risk assessments are performed separately from each other, recent efforts have been made in both disciplines to ...
Elizabeth Dufourcq Sekatcheff, Jaeseong Jeong, Jinhee Choi   +2 more
wiley   +1 more source

The je ne sais quoi of 5-methylcytosine in messenger RNA. [PDF]

RNA
Guarnacci M, Preiss T.
europepmc   +1 more source

Matching TGF‐β1 Activation With Stress‐Responsive Charge‐Reversal Hydrogel Microspheres for the Treatment of Osteoarthritis

Exploration, EarlyView.
Based on the interaction between the weakly cross‐linked disulfide bonds that break under stress and charge‐reversal messenger molecules, we herein achieved nanoparticle charge reversal under stress and constructed a stress‐responsive charge‐reversal hydrogel microsphere system using microfluidic technology.
Feng Lin, Yiwen Xu, Lei Xiang, Yueliang Zhu, Yihan Li, Yaping Zhuang, Zengjie Zhang, Jiayu Chen, Heemin Kang, Ning Zhang, Xiaohua Yu, Wenguo Cui   +11 more
wiley   +1 more source

[The function of circular RNA-microRNA-messenger RNA immune regulatory network in childhood allergic asthma]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Huang SH, Zhou JT, Wang Y, Han X.
europepmc   +1 more source

Enhancing Optogenetics‐Based Cancer Therapy Via Nanotechnology

Exploration, EarlyView.
Nanotechnology enhances optogenetics‐based cancer therapy through improved delivery systems and non‐invasive optical regulation. It further enables precise and programmable control of optogenetic living therapeutics for localized antitumor responses.
Honggang Shen, Wenzhe Yi, Rongzhang Li, Shuangshuang Hu, Xindi Qian, Dan Yan, Qian Zou, Guanru Wang, Yaping Li   +8 more
wiley   +1 more source

Messenger RNA Therapy for Female Reproductive Health. [PDF]

Mol Pharm
VanKeulen-Miller R, Fenton OS.
europepmc   +1 more source

A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of Nucleoside-Modified Messenger RNA Influenza Vaccines in Healthy Adults. [PDF]

Vaccines (Basel)
Branche A, Mulligan MJ, Maniar A, Puente O, Oladipupo I, Crowther G, Zareba AM, Yi Z, Scully I, Gomme E, Koury K, Kitchin N, Allen PS, Anderson AS, Gurtman A, Lindert K.   +15 more
europepmc   +1 more source

Integrity assay for messenger RNA in mouse and human brain samples and synaptosomal preparations. [PDF]

iScience
Bujanauskiene D, Merkevicius K, Kuliesiute U, Denkovskij J, Kutanovas S, Luksys G, Rocka S, Bernotiene E, Neniskyte U.   +8 more
europepmc   +1 more source

Role of the circular RNAs/microRNA/messenger RNA axis in renal cell carcinoma: From gene regulation to metabolism and immunity. [PDF]

iScience
Xu Z, Dong Y, Cui K, Hu B, Lu Y, Liu X, Shahzad A, Zhang J, Duan Q, Bai Z, Peng D, Xia J, Liu W, Teng Z, Yang Z, Zhang Q.   +15 more
europepmc   +1 more source